158 related articles for article (PubMed ID: 27785038)
1. Association of medications for lifestyle-related diseases with reflux esophagitis.
Asaoka D; Nagahara A; Hojo M; Matsumoto K; Ueyama H; Matsumoto K; Izumi K; Takeda T; Komori H; Akazawa Y; Shimada Y; Osada T; Watanabe S
Ther Clin Risk Manag; 2016; 12():1507-1515. PubMed ID: 27785038
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?
Asaoka D; Nagahara A; Shimada Y; Matsumoto K; Ueyama H; Matsumoto K; Nakagawa Y; Takeda T; Tanaka I; Sasaki H; Osada T; Hojo M; Watanabe S
Ther Clin Risk Manag; 2015; 11():381-91. PubMed ID: 25834453
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan.
Abe Y; Ohara S; Koike T; Sekine H; Iijima K; Kawamura M; Imatani A; Kato K; Shimosegawa T
Am J Gastroenterol; 2004 Jul; 99(7):1213-21. PubMed ID: 15233656
[TBL] [Abstract][Full Text] [Related]
4. The Relationship between H. pylori Infection and Osteoporosis in Japan.
Asaoka D; Nagahara A; Hojo M; Sasaki H; Shimada Y; Yoshizawa T; Osada T; Watanabe S
Gastroenterol Res Pract; 2014; 2014():340765. PubMed ID: 25024699
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users.
Asaoka D; Takeda T; Sasaki H; Shimada Y; Matsumoto K; Ueyama H; Matsumoto K; Izumi K; Komori H; Akazawa Y; Osada T; Hojo M; Nagahara A
Biomed Rep; 2019 May; 10(5):277-282. PubMed ID: 31086661
[TBL] [Abstract][Full Text] [Related]
6. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan.
Fujiwara Y; Higuchi K; Shiba M; Yamamori K; Watanabe Y; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Am J Gastroenterol; 2005 Apr; 100(4):754-8. PubMed ID: 15784015
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for reflux esophagitis after eradication of
Harada A; Kurahara K; Moriyama T; Tanaka T; Nagata Y; Kawasaki K; Yaita H; Maehata Y; Umeno J; Oshiro Y; Fuchigami T; Kitazono T; Esaki M; Matsumoto T
Scand J Gastroenterol; 2019 Oct; 54(10):1183-1188. PubMed ID: 31577454
[No Abstract] [Full Text] [Related]
8. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.
Csendes A; Smok G; Cerda G; Burdiles P; Mazza D; Csendes P
Dis Esophagus; 1997 Jan; 10(1):38-42. PubMed ID: 9079272
[TBL] [Abstract][Full Text] [Related]
9. The impact of Helicobacter pylori on the presence of Barrett's esophagus in Azerbaijan, a high-prevalence area of infection.
Aghayeva S; Mara KC; Katzka DA
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 31175364
[TBL] [Abstract][Full Text] [Related]
10. Risks of substance uses, alcohol flush response, Helicobacter pylori infection and upper digestive tract diseases-An endoscopy cross-sectional study.
Chuang YS; Wu MC; Wang YK; Chen YH; Kuo CH; Wu DC; Wu MT; Wu IC
Kaohsiung J Med Sci; 2019 Jun; 35(6):341-349. PubMed ID: 31001924
[TBL] [Abstract][Full Text] [Related]
11. Increased prevalence of Helicobacter pylori infection in gastric cardia of patients with reflux esophagitis: a study from Jordan.
Abdul-Razzak KK; Bani-Hani KE
J Dig Dis; 2007 Nov; 8(4):203-6. PubMed ID: 17970877
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population.
Peng S; Cui Y; Xiao YL; Xiong LS; Hu PJ; Li CJ; Chen MH
Endoscopy; 2009 Dec; 41(12):1011-7. PubMed ID: 19967617
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.
Lord RV; Frommer DJ; Inder S; Tran D; Ward RL
Aust N Z J Surg; 2000 Jan; 70(1):26-33. PubMed ID: 10696939
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients.
Pilotto A; Franceschi M; Leandro G; Scarcelli C; D'Ambrosio LP; Seripa D; Perri F; Niro V; Paris F; Andriulli A; Di Mario F
J Am Geriatr Soc; 2006 Oct; 54(10):1537-42. PubMed ID: 17038071
[TBL] [Abstract][Full Text] [Related]
15. Lifestyle- and Comorbidity-Related Risk Factors Associated with Prescription of Gastric Acid Secretion Inhibitors to Japanese Patients Who Were Helicobacter pylori Negative and Had No Upper Gastrointestinal Lesions.
Matsunaga T; Endo H; Takamori A; Shimada F; Takedomi H; Shirai S; Tsuruoka N; Sakata Y; Shimoda R; Anzai K; Node K; Yamanouchi K; Fujimoto K
Digestion; 2021; 102(3):437-445. PubMed ID: 32097905
[TBL] [Abstract][Full Text] [Related]
16. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study.
Rosaida MS; Goh KL
Eur J Gastroenterol Hepatol; 2004 May; 16(5):495-501. PubMed ID: 15097043
[TBL] [Abstract][Full Text] [Related]
17. Reflux esophagitis after eradication of Helicobacter pylori is associated with the degree of hiatal hernia.
Inoue H; Imoto I; Taguchi Y; Kuroda M; Nakamura M; Horiki N; Oka S; Gabazza EC; Adachi Y
Scand J Gastroenterol; 2004 Nov; 39(11):1061-5. PubMed ID: 15545162
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for erosive esophagitis and Barrett's esophagus in a high Helicobacter pylori prevalence area.
Jonaitis L; Kriukas D; Kiudelis G; Kupčinskas L
Medicina (Kaunas); 2011; 47(8):434-9. PubMed ID: 22123558
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of Japanese reflux esophagitis patients as determined by Los Angeles classification.
Inamori M; Togawa J; Nagase H; Abe Y; Umezawa T; Nakajima A; Saito T; Ueno N; Tanaka K; Sekihara H; Kaifu H; Tsuboi H; Kayama H; Tominaga S; Nagura H
J Gastroenterol Hepatol; 2003 Feb; 18(2):172-6. PubMed ID: 12542602
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
